icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Long-term impact of HCV eradication after alloral
therapy in patients with clinical significant portal hypertension

 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Saturday Parallel session: Clinical impact of HCV cure
 
S Lens1, E Alvarado-Tapias2, Z Marino1, J Martinez3, MC Londono1, E LLop4, JI Fortea5, L Ibanez6, R Banares6, A Puente5, A Albillos3, JL Calleja4, X Torras2, Anna Baiges1, Virginia Hernandez-Gea1, J Bosch1, C Villanueva2, X Forns1, JC García-Pagan1
1.Liver Unit, Hospital Clinic, Barcelona. Universidad de Barcelona. IDIBAPS. CIBEREHD. 2.Gastroenterology Department, Hospital Santa Creu I Sant Pau, Barcelona 3.Gastroenterology and Hepatology Department, Hospital Ramon y Cajal. Universidad de Alcala. Madrid. CIBEREHD. 4.Liver Unit, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid. 5.Digestive Diseases Department, Marques de Valdecilla University Hospital.IDIVAL. Santander. Spain 6.Liver Unit, Hospital Gregorio Maranón. Madrid

0416181

0416182

0416183

0416184

0416185

0416186

0416187

0416188